Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EZPRF is a medical technology company that specializes in Platelet-Rich Fibrin (PRF) systems, marketed as "The Ultimate Blood Concentrate." The company provides a proprietary system designed to produce a high-quality autologous fibrin scaffold enriched with platelets, white blood cells, and mesenchymal stem cells without the use of anticoagulants or synthetic additives. Their technology is widely utilized in aesthetic medicine for skin rejuvenation and hair restoration, as well as in dental and orthopedic applications for tissue regeneration. EZPRF offers a comprehensive ecosystem including specialized centrifuges, collection tubes, and educational training for healthcare practitioners. By focusing on natural, patient-derived biologics, the company has established itself as a leader in the regenerative aesthetics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EZ PRF.